1. Wali R, Fadoo Z, Adil S, Naqvi MA. Aplastic anemia: clinicohaematological features, treatment and outcome analysis. J Coll Physicians Surg Pak. 2011;21:219–22.
2. Julen K, Volken T, Holbro A, et al. Transfusions in aplastic anemia patients cause HLA alloimmunization: comparisons of current and past cohorts demonstrate progress. Transplant Cell Ther. 2021;27:939.e1-8.
3. Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets. 2015;26:190–4.
4. Liu W, Wu D, Hu T, Ye B. Efficiency of treatment with rituximab in platelet transfusion refractoriness: a study of 7 cases. Int J Clin Exp Med. 2015;8:14080–4.